Human Astrocytes Transfer Aggregated Alpha-Synuclein via Tunneling Nanotubes

Abstract

Many lines of evidence suggest that the Parkinson's disease (PD)-related protein α-synuclein (α-SYN) can propagate from cell to cell in a prion-like manner. However, the cellular mechanisms behind the spreading remain elusive. Here, we show that human astrocytes derived from embryonic stem cells actively transfer aggregated α-SYN to nearby astrocytes via direct contact and tunneling nanotubes (TNTs). Failure in the astrocytes' lysosomal digestion of excess α-SYN oligomers results in α-SYN deposits in the trans-Golgi network followed by endoplasmic reticulum swelling and mitochondrial disturbances. The stressed astrocytes respond by conspicuously sending out TNTs, enabling intercellular transfer of α-SYN to healthy astrocytes, which in return deliver mitochondria, indicating a TNT-mediated rescue mechanism. Using a pharmacological approach to inhibit TNT formation, we abolished the transfer of both α-SYN and mitochondria. Together, our results highlight the role of astrocytes in α-SYN cell-to-cell transfer, identifying possible pathophysiological events in the PD brain that could be of therapeutic relevance. SIGNIFICANCE STATEMENT Astrocytes are the major cell type in the brain, yet their role in Parkinson's disease progression remains elusive. Here, we show that human astrocytes actively transfer aggregated α-synuclein (α-SYN) to healthy astrocytes via direct contact and tunneling nanotubes (TNTs), rather than degrade it. The astrocytes engulf large amounts of oligomeric α-SYN that are subsequently stored in the trans-Golgi network region. The accumulation of α-SYN in the astrocytes affects their lysosomal machinery and induces mitochondrial damage. The stressed astrocytes respond by sending out TNTs, enabling intercellular transfer of α-SYN to healthy astrocytes. Our findings highlight an unexpected role of astrocytes in the propagation of α-SYN pathology via TNTs, revealing astrocytes as a potential target for therapeutic intervention.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 74

1. 1.

   Abounit S, Bousset L, Loria F, Zhu S, de Chaumont F, Pieri L, Olivo-Marin JC, Melki R, Zurzolo C (2016 ) Tunneling nanotubes spread fibrillar alpha-synuclein by intercellular trafficking of lysosomes. EMBO J 35:2120–2138.

   Not in our library10.15252/embj.201593411

2. 2.
   Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission · 2011

   No notice
3. 3.

   Appelqvist H, Wäster P, Kågedal K, Öllinger K (2013 ) The lysosome: from waste bag to potential therapeutic target. J Mol Cell Biol 5:214–226.

   Not in our library10.1093/jmcb/mjt022

4. 4.

   Bonifacino JS, Rojas R (2006 ) Retrograde transport from endosomes to the trans-Golgi network. Nat Rev Mol Cell Biol 7:568–579.

   Not in our library10.1038/nrm1985

5. 5.

   Braak H, Sastre M, Del Tredici K (2007 ) Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease. Acta Neuropathol 114:231–241.

   Not in our library10.1007/s00401-007-0244-3

6. 6.

   Bukoreshtliev NV, Wang X, Hodneland E, Gurke S, Barroso JF, Gerdes HH (2009 ) Selective block of tunneling nanotube (TNT) formation inhibits intercellular organelle transfer between PC12 cells. FEBS Lett 583:1481–1488.

   Not in our library10.1016/j.febslet.2009.03.065

7. 7.

   Chang GH, Barbaro NM, Pieper RO (2000 ) Phosphatidylserine-dependent phagocytosis of apoptotic glioma cells by normal human microglia, astrocytes, and glioma cells. Neuro Oncol 2:174–183.

   Not in our library10.1093/neuonc/2.3.174

8. 8.

   Chinta SJ, Mallajosyula JK, Rane A, Andersen JK (2010 ) Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo. Neurosci Lett 486:235–239.

   Not in our library10.1016/j.neulet.2010.09.061

9. 9.

   Chung WS, Clarke LE, Wang GX, Stafford BK, Sher A, Chakraborty C, Joung J, Foo LC, Thompson A, Chen C, Smith SJ, Barres BA (2013 ) Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways. Nature 504:394–400.

   Not in our library10.1038/nature12776

10. 10.

    Cooper AA, Gitler AD, Cashikar A, Haynes CM, Hill KJ, Bhullar B, Liu K, Xu K, Strathearn KE, Liu F, Cao S, Caldwell KA, Caldwell GA, Marsischky G, Kolodner RD, Labaer J, Rochet JC, Bonini NM, Lindquist S (2006 ) Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 313:324–328.

    Not in our library10.1126/science.1129462

11. 11.

    Cornet A, Bettelli E, Oukka M, Cambouris C, Avellana-Adalid V, Kosmatopoulos K, Liblau RS (2000 ) Role of astrocytes in antigen presentation and naive T-cell activation. J Neuroimmunol 106:69–77.

    Not in our library10.1016/s0165-5728(99)00215-5

12. 12.

    Coulter DA, Eid T (2012 ) Astrocytic regulation of glutamate homeostasis in epilepsy. Glia 60:1215–1226.

    Not in our library10.1002/glia.22341

13. 13.

    Croisier E, Graeber MB (2006 ) Glial degeneration and reactive gliosis in alpha-synucleinopathies: the emerging concept of primary gliodegeneration. Acta Neuropathol 112:517–530.

    Not in our library10.1007/s00401-006-0119-z

14. 14.

    Danzer KM, Haasen D, Karow AR, Moussaud S, Habeck M, Giese A, Kretzschmar H, Hengerer B, Kostka M (2007 ) Different species of alpha-synuclein oligomers induce calcium influx and seeding. J Neurosci 27:9220–9232.

    Not in our library10.1523/jneurosci.2617-07.2007

15. 15.

    Danzer KM, Ruf WP, Putcha P, Joyner D, Hashimoto T, Glabe C, Hyman BT, McLean PJ (2011 ) Heat-shock protein 70 modulates toxic extracellular alpha-synuclein oligomers and rescues trans-synaptic toxicity. FASEB J 25:326–336.

    Not in our library10.1096/fj.10-164624

16. 16.

    Desplats P, Lee HJ, Bae EJ, Patrick C, Rockenstein E, Crews L, Spencer B, Masliah E, Lee SJ (2009 ) Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci U S A 106:13010–13015.

    Not in our library10.1073/pnas.0903691106

17. 17.

    Di Malta C, Fryer JD, Settembre C, Ballabio A (2012 ) Astrocyte dysfunction triggers neurodegeneration in a lysosomal storage disorder. Proc Natl Acad Sci U S A 109:E2334–2342.

    Not in our library10.1073/pnas.1209577109

18. 18.
    Assessment of α-Synuclein Secretion in Mouse and Human Brain Parenchyma · 2011

    No notice
19. 19.

    Eroglu C, Barres BA (2010 ) Regulation of synaptic connectivity by glia. Nature 468:223–231.

    Not in our library10.1038/nature09612

20. 20.

    Evans E, Leung A, Zhelev D (1993 ) Synchrony of cell spreading and contraction force as phagocytes engulf large pathogens. J Cell Biol 122:1295–1300.

    Not in our library10.1083/jcb.122.6.1295

21. 21.
    Toll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astroglia · 2012

    No notice
22. 22.

    Giaume C, Kirchhoff F, Matute C, Reichenbach A, Verkhratsky A (2007 ) Glia: the fulcrum of brain diseases. Cell Death Differ 14:1324–1335.

    Not in our library10.1038/sj.cdd.4402144

23. 23.

    Gousset K, Schiff E, Langevin C, Marijanovic Z, Caputo A, Browman DT, Chenouard N, de Chaumont F, Martino A, Enninga J, Olivo-Marin JC, Männel D, Zurzolo C (2009 ) Prions hijack tunnelling nanotubes for intercellular spread. Nat Cell Biol 11:328–336.

    Not in our library10.1038/ncb1841

24. 24.

    Guardia-Laguarta C, Area-Gomez E, Rüb C, Liu Y, Magrané J, Becker D, Voos W, Schon EA, Przedborski S (2014 ) alpha-Synuclein is localized to mitochondria-associated ER membranes. J Neurosci 34:249–259.

    Not in our library10.1523/jneurosci.2507-13.2014

25. 25.

    Gui YX, Wang XY, Kang WY, Zhang YJ, Zhang Y, Zhou Y, Quinn TJ, Liu J, Chen SD (2012 ) Extracellular signal-regulated kinase is involved in alpha-synuclein-induced mitochondrial dynamic disorders by regulating dynamin-like protein 1. Neurobiol Aging 33:2841–2854.

    Not in our library10.1016/j.neurobiolaging.2012.02.001

26. 26.

    Han H, Hu J, Yan Q, Zhu J, Zhu Z, Chen Y, Sun J, Zhang R (2016 ) Bone marrow-derived mesenchymal stem cells rescue injured H9c2 cells via transferring intact mitochondria through tunneling nanotubes in an in vitro simulated ischemia/reperfusion model. Mol Med Rep 13:1517–1524.

    Not in our library10.3892/mmr.2015.4726

27. 27.

    Hansen C, Angot E, Bergström AL, Steiner JA, Pieri L, Paul G, Outeiro TF, Melki R, Kallunki P, Fog K, Li JY, Brundin P (2011 ) alpha-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. J Clin Invest 121:715–725.

    Not in our library10.1172/jci43366

28. 28.
    Generation of human pluripotent stem cell reporter lines for the isolation of and reporting on astrocytes generated from ventral midbrain and ventral spinal cord neural progenitors · 2015

    Not checked
29. 29.
    Mitochondrial Transfer via Tunneling Nanotubes is an Important Mechanism by Which Mesenchymal Stem Cells Enhance Macrophage Phagocytosis in the In Vitro and In Vivo Models of ARDS · 2016

    No notice
30. 30.

    Jang A, Lee HJ, Suk JE, Jung JW, Kim KP, Lee SJ (2010 ) Non-classical exocytosis of alpha-synuclein is sensitive to folding states and promoted under stress conditions. J Neurochem 113:1263–1274.

    Not in our library10.1111/j.1471-4159.2010.06695.x

31. 31.
    Mitochondrial transfer of mesenchymal stem cells effectively protects corneal epithelial cells from mitochondrial damage · 2016

    No notice
32. 32.

    Jones RS, Minogue AM, Connor TJ, Lynch MA (2013 ) Amyloid-beta-induced astrocytic phagocytosis is mediated by CD36, CD47 and RAGE. J Neuroimmune Pharmacol 8:301–311.

    Not in our library10.1007/s11481-012-9427-3

33. 33.

    Katsuragi Y, Ichimura Y, Komatsu M (2015 ) p62/SQSTM1 functions as a signaling hub and an autophagy adaptor. FEBS J 282:4672–4678.

    Not in our library10.1111/febs.13540

34. 34.

    Kimura S, Hase K, Ohno H (2013 ) The molecular basis of induction and formation of tunneling nanotubes. Cell Tissue Res 352:67–76.

    Not in our library10.1007/s00441-012-1518-1

35. 35.

    Klionsky DJ, et al (2016 ) Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 12:1–222.

    Not in our library10.1080/15548627.2015.1100356

36. 36.

    Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW (2008 ) Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med 14:504–506.

    Not in our library10.1038/nm1747

37. 37.

    Lee HJ, Suk JE, Patrick C, Bae EJ, Cho JH, Rho S, Hwang D, Masliah E, Lee SJ (2010 ) Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J Biol Chem 285:9262–9272.

    Not in our library10.1074/jbc.m109.081125

38. 38.

    Li JY, Englund E, Holton JL, Soulet D, Hagell P, Lees AJ, Lashley T, Quinn NP, Rehncrona S, Björklund A, Widner H, Revesz T, Lindvall O, Brundin P (2008 ) Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med 14:501–503.

    Not in our library10.1038/nm1746

39. 39.

    Lindström V, Gustafsson G, Sanders LH, Howlett EH, Sigvardson J, Kasrayan A, Ingelsson M, Bergström J, Erlandsson A (2017 ) Extensive uptake of alpha-synuclein oligomers in astrocytes results in sustained intracellular deposits and mitochondrial damage. Mol Cell Neurosci 82:143–156.

    Not in our library10.1016/j.mcn.2017.04.009

40. 40.
    Engulfing Astrocytes Protect Neurons from Contact-Induced Apoptosis following Injury · 2012

    No notice
41. 41.

    Lööv C, Mitchell CH, Simonsson M, Erlandsson A (2015 ) Slow degradation in phagocytic astrocytes can be enhanced by lysosomal acidification. Glia 63:1997–2009.

    Not in our library10.1002/glia.22873

42. 42.

    Luth ES, Stavrovskaya IG, Bartels T, Kristal BS, Selkoe DJ (2014 ) Soluble, prefibrillar alpha-synuclein oligomers promote complex I-dependent, Ca2+-induced mitochondrial dysfunction. J Biol Chem 289:21490–21507.

    Not in our library10.1074/jbc.m113.545749

43. 43.

    Magnus T, Chan A, Linker RA, Toyka KV, Gold R (2002 ) Astrocytes are less efficient in the removal of apoptotic lymphocytes than microglia cells: implications for the role of glial cells in the inflamed central nervous system. J Neuropathol Exp Neurol 61:760–766.

    Not in our library10.1093/jnen/61.9.760

44. 44.

    Mazzulli JR, Xu YH, Sun Y, Knight AL, McLean PJ, Caldwell GA, Sidransky E, Grabowski GA, Krainc D (2011 ) Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 146:37–52.

    Not in our library10.1016/j.cell.2011.06.001

45. 45.

    Mazzulli JR, Zunke F, Isacson O, Studer L, Krainc D (2016 ) alpha-Synuclein-induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models. Proc Natl Acad Sci U S A 113:1931–1936.

    Not in our library10.1073/pnas.1520335113

46. 46.

    Nakamura K (2013 ) alpha-Synuclein and mitochondria: partners in crime? Neurotherapeutics 10:391–399.

    Not in our library10.1007/s13311-013-0182-9

47. 47.

    Näsström T, Fagerqvist T, Barbu M, Karlsson M, Nikolajeff F, Kasrayan A, Ekberg M, Lannfelt L, Ingelsson M, Bergström J (2011 ) The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of alpha-synuclein oligomers with distinct biochemical, morphological, and functional properties. Free Radic Biol Med 50:428–437.

    Not in our library10.1016/j.freeradbiomed.2010.11.027

48. 48.

    Nixon RA (2007 ) Autophagy, amyloidogenesis and Alzheimer disease. J Cell Sci 120:4081–4091.

    Not in our library10.1242/jcs.019265

49. 49.

    Nixon RA, Yang DS, Lee JH (2008 ) Neurodegenerative lysosomal disorders: a continuum from development to late age. Autophagy 4:590–599.

    Not in our library10.4161/auto.6259

50. 50.

    Ogen-Shtern N, Ben David T, Lederkremer GZ (2016 ) Protein aggregation and ER stress. Brain Res 1648:658–666.

    Not in our library10.1016/j.brainres.2016.03.044

51. 51.

    Rappold PM, Tieu K (2010 ) Astrocytes and therapeutics for Parkinson's disease. Neurotherapeutics 7:413–423.

    Not in our library10.1016/j.nurt.2010.07.001

52. 52.
    Alpha-synuclein spreading in Parkinson’s disease · 2014

    No notice
53. 53.

    Rustom A, Saffrich R, Markovic I, Walther P, Gerdes HH (2004 ) Nanotubular highways for intercellular organelle transport. Science 303:1007–1010.

    Not in our library10.1126/science.1093133

54. 54.

    Ryan BJ, Hoek S, Fon EA, Wade-Martins R (2015 ) Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease. Trends Biochem Sci 40:200–210.

    Not in our library10.1016/j.tibs.2015.02.003

55. 55.

    Sisakhtnezhad S, Khosravi L (2015 ) Emerging physiological and pathological implications of tunneling nanotubes formation between cells. Eur J Cell Biol 94:429–443.

    Not in our library10.1016/j.ejcb.2015.06.010

56. 56.

    Sofroniew MV, Vinters HV (2010 ) Astrocytes: biology and pathology. Acta Neuropathol 119:7–35.

    Not in our library10.1007/s00401-009-0619-8

57. 57.

    Sokolowski JD, Nobles SL, Heffron DS, Park D, Ravichandran KS, Mandell JW (2011 ) Brain-specific angiogenesis inhibitor-1 expression in astrocytes and neurons: implications for its dual function as an apoptotic engulfment receptor. Brain Behav Immun 25:915–921.

    Not in our library10.1016/j.bbi.2010.09.021

58. 58.
    Accumulation of amyloid-β by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neurons · 2016

    No notice
59. 59.

    Spees JL, Olson SD, Whitney MJ, Prockop DJ (2006 ) Mitochondrial transfer between cells can rescue aerobic respiration. Proc Natl Acad Sci U S A 103:1283–1288.

    Not in our library10.1073/pnas.0510511103

60. 60.

    Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997 ) Alpha-synuclein in Lewy bodies. Nature 388:839–840.

    Not in our library10.1038/42166

61. 61.

    Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M (1998 ) alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc Natl Acad Sci U S A 95:6469–6473.

    Not in our library10.1073/pnas.95.11.6469

62. 62.

    Terada S, Ishizu H, Yokota O, Tsuchiya K, Nakashima H, Ishihara T, Fujita D, Uéda K, Ikeda K, Kuroda S (2003 ) Glial involvement in diffuse Lewy body disease. Acta Neuropathol 105:163–169.

    Not in our library10.1007/s00401-002-0622-9

63. 63.

    Tu PH, Galvin JE, Baba M, Giasson B, Tomita T, Leight S, Nakajo S, Iwatsubo T, Trojanowski JQ, Lee VM (1998 ) Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein. Ann Neurol 44:415–422.

    Not in our library10.1002/ana.410440324

64. 64.

    Verkhratsky A, Sofroniew MV, Messing A, deLanerolle NC, Rempe D, Rodriguez JJ, Nedergaard M (2012 ) Neurological diseases as primary gliopathies: a reassessment of neurocentrism. ASN Neuro 4: pii: e00082.

    Not in our library10.1042/an20120010

65. 65.

    Verkhratsky A, Rodríguez JJ, Parpura V (2013 ) Astroglia in neurological diseases. Future Neurol 8:149–158.

    Not in our library10.2217/fnl.12.90

66. 66.

    Verkhratsky A, Nedergaard M, Hertz L (2015 ) Why are astrocytes important? Neurochem Res 40:389–401.

    Not in our library10.1007/s11064-014-1403-2

67. 67.

    Victoria GS, Arkhipenko A, Zhu S, Syan S, Zurzolo C (2016 ) Astrocyte-to-neuron intercellular prion transfer is mediated by cell-cell contact. Sci Rep 6:20762.

    Not in our library10.1038/srep20762

68. 68.

    Wakabayashi K, Hayashi S, Yoshimoto M, Kudo H, Takahashi H (2000 ) NACP/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains. Acta Neuropathol 99:14–20.

    Not in our library10.1007/pl00007400

69. 69.
    Transfer of mitochondria via tunneling nanotubes rescues apoptotic PC12 cells · 2015

    No notice
70. 70.

    Wang X, Bukoreshtliev NV, Gerdes HH (2012 ) Developing neurons form transient nanotubes facilitating electrical coupling and calcium signaling with distant astrocytes. PLoS One 7:e47429.

    Not in our library10.1371/journal.pone.0047429

71. 71.

    Wang Y, Cui J, Sun X, Zhang Y (2011 ) Tunneling-nanotube development in astrocytes depends on p53 activation. Cell Death Differ 18:732–742.

    Not in our library10.1038/cdd.2010.147

72. 72.

    Winner B, Jappelli R, Maji SK, Desplats PA, Boyer L, Aigner S, Hetzer C, Loher T, Vilar M, Campioni S, Tzitzilonis C, Soragni A, Jessberger S, Mira H, Consiglio A, Pham E, Masliah E, Gage FH, Riek R (2011 ) In vivo demonstration that alpha-synuclein oligomers are toxic. Proc Natl Acad Sci U S A 108:4194–4199.

    Not in our library10.1073/pnas.1100976108

73. 73.

    Winslow AR, Chen CW, Corrochano S, Acevedo-Arozena A, Gordon DE, Peden AA, Lichtenberg M, Menzies FM, Ravikumar B, Imarisio S, Brown S, O'Kane CJ, Rubinsztein DC (2010 ) alpha-Synuclein impairs macroautophagy: implications for Parkinson's disease. J Cell Biol 190:1023–1037.

    Not in our library10.1083/jcb.201003122

74. 74.

    Zhu D, Tan KS, Zhang X, Sun AY, Sun GY, Lee JC (2005 ) Hydrogen peroxide alters membrane and cytoskeleton properties and increases intercellular connections in astrocytes. J Cell Sci 118:3695–3703.

    Not in our library10.1242/jcs.02507

Cited by papers we hold 18

• Astrocyte alterations in α-synucleinopathies · 2025
  Not checked
• Lysosomal acidification dysfunction in microglia: an emerging pathogenic mechanism of neuroinflammation and neurodegeneration · 2023
  No notice
• Tunnelling nanotubes between neuronal and microglial cells allow bi-directional transfer of α-Synuclein and mitochondria · 2023
  No notice
• Microglia and Astrocyte Function and Communication: What Do We Know in Humans? · 2022
  No notice
• Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities · 2022
  No notice
• Crosstalk between astrocytes and microglia results in increased degradation of α-synuclein and amyloid-β aggregates · 2021
  No notice
• The Pathogenesis of Parkinson's Disease: A Complex Interplay Between Astrocytes, Microglia, and T Lymphocytes? · 2021
  No notice
• Selective targeting of the TLR2/MyD88/NF-κB pathway reduces α-synuclein spreading in vitro and in vivo · 2021
  No notice
• Intercellular mitochondrial transfer as a means of tissue revitalization · 2021
  No notice
• Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes · 2021
  No notice
• Astrocytes have the capacity to act as antigen-presenting cells in the Parkinson’s disease brain · 2020
  No notice
• Alpha-Synuclein Physiology and Pathology: A Perspective on Cellular Structures and Organelles · 2020
  No notice
• Prion-Like Mechanisms in Parkinson’s Disease · 2019
  Not checked
• Mechanisms of secretion and spreading of pathological tau protein · 2019
  No notice
• α-synuclein in the pathophysiology of Alzheimer’s disease · 2019
  No notice
• Glial phagocytic clearance in Parkinson’s disease · 2019
  No notice
• Astrocyte Heterogeneity: Impact to Brain Aging and Disease · 2019
  No notice
• Invited Review: APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer's disease · 2018
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.